CSL’s $800 million vaccine manufacturing facility in Melbourne nears completion

CSL Seqirus has reached a major milestone in the construction of its new cutting-edge manufacturing facility for vaccine and antivenom manufacturing.  The $800 million Tullamarine-based facility is now at its highest point of construction known as “topping out,” which is marked by the completion of roofing laying on the building. The manufacturing facility will have CSL […]

Startups join CSL, Moderna in local mRNA vaccine manufacturing push

Home-grown biotech startups and small businesses have joined pharmaceutical giants like CSL in pitching to the federal government for a role in making mRNA products in Australia. The Department of Industry, Science, Energy and Resources had asked Australian biotechs to submit blueprints for how they would make products using technology like that used to make […]

CSL to make vaccine in Australia

A COVID-19 vaccine is yet to achieve clinical approval, but doses will start to be manufactured in Australia this week. CSL on Sunday confirmed it will commence manufacturing the University of Oxford/AstraZeneca coronavirus vaccine candidate in Victoria from Monday. The ASX-listed biotechnology company has separate contracts with AstraZeneca and the federal government to manufacture approximately […]